• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Substituting traditional antipsychotics with risperidone for individuals with mental retardation.

作者信息

Simon E W, Blubaugh K M, Pippidis M

机构信息

Elwyn Inc., Elwyn, PA 19063, USA.

出版信息

Ment Retard. 1996 Dec;34(6):359-66.

PMID:8990820
Abstract

The use of risperidone for 10 individuals with mental retardation and mental health disturbances was reported. A case study approach was employed to delineate the course of substitution of more traditional antipsychotic medications with risperidone. At the conclusion of the study, 6 of the 10 individuals had completed the substitution protocol. All participants evidenced improvement or resolution in side effects attributed to previous antipsychotic medication, with no worsening in psychiatric or behavioral status.

摘要

相似文献

1
Substituting traditional antipsychotics with risperidone for individuals with mental retardation.
Ment Retard. 1996 Dec;34(6):359-66.
2
Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.智力障碍中行为障碍的治疗:关于向非典型抗精神病药物过渡的报告,重点是利培酮。
J Clin Psychiatry. 2004 Sep;65(9):1197-210.
3
The use of risperidone among individuals with mental retardation: clinically supported or not?在智力迟钝个体中使用利培酮:是否有临床依据?
Res Dev Disabil. 2005 May-Jun;26(3):203-18. doi: 10.1016/j.ridd.2004.07.001.
4
Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.患有精神疾病的老年人使用精神药物,特别是抗精神病药物:对不同诊断组耐受性和使用情况的系统研究
Int J Geriatr Psychiatry. 2005 Sep;20(9):842-7. doi: 10.1002/gps.1365.
5
Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.利培酮治疗严重迟发性运动障碍:一项为期12周的随机、双盲、安慰剂对照研究。
J Clin Psychiatry. 2003 Nov;64(11):1342-8.
6
Using antipsychotic agents in older patients.在老年患者中使用抗精神病药物。
J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4.
7
Movement disorders associated with neuroleptic treatment.与抗精神病药物治疗相关的运动障碍。
J Clin Psychiatry. 2001;62 Suppl 21:15-8.
8
[Risperidone in the treatment of psychotic disorders associated with mental retardation].
Actas Esp Psiquiatr. 2000 Jul-Aug;28(4):251-6.
9
Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable.使用利培酮长效注射剂有效治疗的精神分裂症和分裂情感性障碍早期患者。
J Psychopharmacol. 2005 Sep;19(5 Suppl):5-14. doi: 10.1177/0269881105056513.
10
Psychotropic medication in adults with mental retardation: prevalence, and prescription practices.成人智力障碍患者的精神药物治疗:患病率及处方实践。
Res Dev Disabil. 2004 Nov-Dec;25(6):509-21. doi: 10.1016/j.ridd.2004.03.004.

引用本文的文献

1
Behavioral disorder in people with an intellectual disability and epilepsy: A report of the Intellectual Disability Task Force of the Neuropsychiatric Commission of ILAE.智力残疾和癫痫患者的行为障碍:国际抗癫痫联盟神经精神委员会智力残疾特别工作组的报告
Epilepsia Open. 2016 Sep 15;1(3-4):102-111. doi: 10.1002/epi4.12018. eCollection 2016 Dec.
2
Risperidone treatment in 12 children with developmental disorders and attention-deficit/hyperactivity disorder.利培酮治疗12例发育障碍和注意力缺陷/多动障碍儿童。
Prim Care Companion J Clin Psychiatry. 2005;7(5):221-4. doi: 10.4088/pcc.v07n0502.
3
Short- and long-term efficacy and safety of risperidone in adults with disruptive behavior disorders.
Psychopharmacology (Berl). 2005 May;179(3):629-36. doi: 10.1007/s00213-004-2093-2. Epub 2005 Jan 25.
4
Brief report: two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism.简短报告:利培酮对两名重度智力发育迟缓的自闭症成年人行为症状的两年控制情况
J Autism Dev Disord. 1999 Feb;29(1):87-91. doi: 10.1023/a:1025926817928.